SINULIEF
Live / Applied — Statement of use — processing complete, to examiner (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 17 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98653939
- Mark type
- Stylized text
- Filed
- 17 Jul 2024
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Nathaniel A. Wickliffe
Goods and services
- Class 005 — Pharmaceuticals: Antihistamines; Allergy medications; Allergy relief medication; Antiallergic medicines; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for treating allergies
Owner
- RoseWell Pharmaceuticals LLC, San Diego, CA, US
- RoseWell Pharmaceuticals LLC, San Diego, CA, US
Prosecution history
- 27 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Nov 2025 — USE AMENDMENT FILED
- 27 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Nov 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 16 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Aug 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 08 Aug 2025 — LETTER OF SUSPENSION E-MAILED
- 08 Aug 2025 — SUSPENSION LETTER WRITTEN
- 07 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE